Invention Grant
- Patent Title: Morpholine derivative
-
Application No.: US16898827Application Date: 2020-06-11
-
Publication No.: US11312711B2Publication Date: 2022-04-26
- Inventor: Guido Galley , Marius Hoener , Roger Norcross , Philippe Pflieger
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Bradley E. Davis
- Priority: EP16160790 20160317
- Main IPC: C07D413/12
- IPC: C07D413/12 ; A61P25/28 ; A61P25/22 ; A61P25/08 ; A61P25/06 ; A61P25/24 ; A61P3/04 ; A61P3/10 ; A61P9/12
Abstract:
The present invention relates to a compound of formula and to a pharmaceutically suitable acid addition salt thereof with a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1, for the treatment of certain CNS diseases.
Public/Granted literature
- US20210122743A1 MORPHOLINE DERIVATIVE Public/Granted day:2021-04-29
Information query
